CavaGene harnesses genomic and AI technology to deliver early, personalized cancer diagnostics through non-invasive, saliva-based testing—bridging innovative research with practical healthcare solutions.
Comprehensive Biomarker Detection: Uses advanced AI to detect a broad range of cancer markers with reduced false positives.
Rapid, Non-Invasive Testing: Saliva-based testing delivers results within 48 hours for accessible diagnostics.
Dynamic Risk Profiling: Continuously adjusts cancer risk probabilities by integrating genetic, environmental, and lifestyle factors.
David Hur, Stern E.M.B.A. ’26
